From owner-freebsd-chat@FreeBSD.ORG  Mon May  5 20:44:37 2003
Return-Path: <owner-freebsd-chat@FreeBSD.ORG>
Delivered-To: freebsd-chat@freebsd.org
Received: from mx1.FreeBSD.org (mx1.freebsd.org [216.136.204.125])
	by hub.freebsd.org (Postfix) with ESMTP id 8A5A537B401
	for <chat@freebsd.org>; Mon,  5 May 2003 20:44:37 -0700 (PDT)
Received: from ariel.ucs.unimelb.edu.au (ariel.ucs.unimelb.edu.au
	[128.250.20.3])	by mx1.FreeBSD.org (Postfix) with ESMTP id 13FB643F93
	for <chat@freebsd.org>; Mon,  5 May 2003 20:44:36 -0700 (PDT)
	(envelope-from jrhoden@unimelb.edu.au)
Received: from elkanah.its.unimelb.edu.au (elkanah.its.unimelb.edu.au
	[128.250.18.41])h463iUVS021871;	Tue, 6 May 2003 13:44:34 +1000 (EST)
From: JacobRhoden <jrhoden@unimelb.edu.au>
Organization: University of Melbourne
To: Terry Lambert <tlambert2@mindspring.com>,
	Brett Glass <brett@lariat.org>
Date: Tue, 6 May 2003 13:44:30 +1000
User-Agent: KMail/1.5
References: <4.3.2.7.2.20030504213212.03a5f140@localhost>
	<4.3.2.7.2.20030505082225.03cc5ec0@localhost>
	<3EB72E3B.1A77D437@mindspring.com>
In-Reply-To: <3EB72E3B.1A77D437@mindspring.com>
MIME-Version: 1.0
Content-Type: text/plain;
  charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Disposition: inline
Message-Id: <200305061344.30358.jrhoden@unimelb.edu.au>
cc: chat@freebsd.org
Subject: Re: open source license with 24 month proprietary clause
X-BeenThere: freebsd-chat@freebsd.org
X-Mailman-Version: 2.1.1
Precedence: list
List-Id: Non technical items related to the community
	<freebsd-chat.freebsd.org>
List-Unsubscribe: <http://lists.freebsd.org/mailman/listinfo/freebsd-chat>,
	<mailto:freebsd-chat-request@freebsd.org?subject=unsubscribe>
List-Archive: <http://lists.freebsd.org/pipermail/freebsd-chat>
List-Post: <mailto:freebsd-chat@freebsd.org>
List-Help: <mailto:freebsd-chat-request@freebsd.org?subject=help>
List-Subscribe: <http://lists.freebsd.org/mailman/listinfo/freebsd-chat>,
	<mailto:freebsd-chat-request@freebsd.org?subject=subscribe>
X-List-Received-Date: Tue, 06 May 2003 03:44:37 -0000

On Tue, 6 May 2003 01:38 pm, Terry Lambert wrote:
> who needs long term treatment with your drug,
> is worth a heck of a lot more long term revenue if you treat them
> instead of curing them.

That is true, but if you are the researcher working for the drug company, your 
motivation is not to make money for your company, you want to be the person 
that cured aids (no one remembers the person who helped temporarily alieve 
something)

 - jacob

Jacob Rhoden            Phone: +61 3 8344 6102
ITS Division            Email: jrhoden@unimelb.edu.au
Melbourne University   Mobile: +61 403 788 386